Sands Capital – RARE history
- Issuer:
- ULTRAGENYX PHARMACEUTICAL IN
- Quarters tracked:
- 7 (Q4 2024 → Q2 2026)
- Current shares:
- 3,158,368
- Current value:
- $105.46M
- Peak shares:
- 4,298,003 (Q4 2024)
- Overall change:
- -27%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 3,158,368 | $105.46M | $33.39 | -56,165 | -2% |
| Q1 2026 | 3,214,533 | $67.34M | $20.95 | -271,191 | -8% |
| Q4 2025 | 3,485,724 | $80.17M | $23.00 | -284,129 | -8% |
| Q3 2025 | 3,769,853 | $113.40M | $30.08 | -173,632 | -4% |
| Q2 2025 | 3,943,485 | $143.38M | $36.36 | -220,076 | -5% |
| Q1 2025 | 4,163,561 | $150.76M | $36.21 | -134,442 | -3% |
| Q4 2024 | 4,298,003 | $180.82M | $42.07 | — | NEW |